HEAL Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
MINUTES OF PROCEEDINGS
Meeting No. 42
Wednesday, June 11, 2003
The Standing Committee on Health met in camera at 3:23 p.m. this day, in Room 308, West Block, the Chair, Bonnie Brown, presiding.
Members of the Committee present: Bonnie Brown, Jeannot Castonguay, Brenda Chamberlain, Stan Dromisky, Raymonde Folco, Hon. Hedy Fry, Betty Hinton, Réal Ménard, Svend Robinson, Carol Skelton and Yolande Thibeault.
Acting Member present: Robert Bertrand for Hélène Scherrer.
In attendance: From the Library of Parliament: Nancy Miller Chenier and Sonya Norris, research officers.
Pursuant to Standing Order 108(2) and the motion adopted by the Committee on February 17, 2003, the Committee resumed consideration of its study on prescription drugs.
It was agreed, -- That, pursuant to Standing Order 108(2), the Committee undertake a study on prescription drugs under the following terms of reference:
1. To gather evidence on the health aspects of the following issues relative to prescription drugs (patented and generic) in Canada:
(a) Rising costs;
(b) Mechanisms for reviewing and controlling prices of all prescription drugs;
(c) Mechanisms for approving new drugs and introducing them onto the market, with respect to their therapeutic value, their side effects, their interactions with other drugs, etc., as well as a focus on clinical trials;
(d) Monitoring of adverse effects and prescribing practices;
(e) Marketing to and lobbying of prescribers and dispensers;
(f) Direct-to-consumer advertising;
(g) Consumer and health professional access to drugs, including but not limited to access to new drugs for new diseases and old drugs for old diseases (excluding commentary on provincial formularies);
(h) Misuse, abuse and addiction within the general population; and,
(i) International comparisons.
2. To examine the evidence gathered with respect to these issues;
3. To discuss the implications of the evidence for Canadians;
4. To make recommendations for future actions.
It was agreed, - That the Clerk of the Committee, in consultation with the Chair, issue a news release to announce the Committee’s study on prescription drugs and to invite the public to submit briefs and requests to appear in relation to the study.
Pursuant to Standing Order 108(2), the Committee resumed consideration of its study on First Nations and Inuit dental health.
It was agreed, - That, pursuant to Standing Order 108(1)(a), the Committee authorize the printing of brief dissenting and/or supplementary opinions as appendices to this report, immediately after the signature of the Chair, and that the opinions be sent to the Clerk of the Committee in electronic form in both official languages on or before noon, Thursday, June 12, 2003.
It was agreed, - That the Chair, or her designate, be authorized to present the report to the House.
At 3:52 p.m., the Committee adjourned to the call of the Chair.
José Cadorette
Clerk of the Committee